Deletion of liaR Reverses Daptomycin Resistance in Enterococcus faecium Independent of the Genetic Background

Diana Panesso; Jinnethe Reyes; Elizabeth P. Gaston; Morgan Deal; Alejandra Londoño; Masayuki Nigo; MUNITA SEPULVEDA, JOSE MANUEL; William R. Miller; Yousif Shamoo; Truc T. Tran; Cesar A. Arias

Deletion of liaR Reverses Daptomycin Resistance in Enterococcus faecium Independent of the Genetic Background

Journal

Antimicrobial Agents and Chemotherapy

ISSN

0066-4804

1098-6596

Date Issued

2015

Author(s)

Diana Panesso

Jinnethe Reyes

Elizabeth P. Gaston

Morgan Deal

Alejandra Londoño

Masayuki Nigo

MUNITA SEPULVEDA, JOSE MANUEL

Facultad de Medicina Clínica Alemana Universidad del Desarrollo

William R. Miller

Yousif Shamoo

Truc T. Tran

Cesar A. Arias

Type

Resource Types::text::journal::journal article

DOI

10.1128/AAC.01073-15

URL

https://investigadores.udd.cl/handle/123456789/3176

Abstract

ABSTRACT We have shown previously that changes in LiaFSR, a three-component regulatory system predicted to orchestrate the cell membrane stress response, are important mediators of daptomycin (DAP) resistance in enterococci. Indeed, deletion of the gene encoding the response regulator LiaR in a clinical strain of Enterococcus faecalis reversed DAP resistance (DAP-R) and produced a strain hypersusceptible to antimicrobial peptides. Since LiaFSR is conserved in Enterococcus faecium , we investigated the role of LiaR in a variety of clinical E. faecium strains representing the most common DAP-R genetic backgrounds. Deletion of liaR in DAP-R E. faecium R446F (DAP MIC of 16 μg/ml) and R497F (MIC of 24 μg/ml; harboring changes in LiaRS) strains fully reversed resistance (DAP MICs decreasing to 0.25 and 0.094 μg/ml, respectively). Moreover, DAP at concentrations of 13 μg/ml (achieved with human doses of 12 mg/kg body weight) retained bactericidal activity against the mutants. Furthermore, the liaR deletion derivatives of these two DAP-R strains exhibited increased binding of boron-dipyrromethene difluoride (BODIPY)-daptomycin, suggesting that high-level DAP-R mediated by LiaR in E. faecium involves repulsion of the calcium-DAP complex from the cell surface. In DAP-tolerant strains HOU503F and HOU515F (DAP MICs within the susceptible range but bacteria not killed by DAP concentrations of 5× the MIC), deletion of liaR not only markedly decreased the DAP MICs (0.064 and 0.047 μg/ml, respectively) but also restored the bactericidal activity of DAP at concentrations as low as 4 μg/ml (achieved with human doses of 4 mg/kg). Our results suggest that LiaR plays a relevant role in the enterococcal cell membrane adaptive response to antimicrobial peptides independent of the genetic background and emerges as an attractive target to restore the activity of DAP against multidrug-resistant strains.